These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 18067894
1. An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol. Handa RJ, Pak TR, Kudwa AE, Lund TD, Hinds L. Horm Behav; 2008 May; 53(5):741-52. PubMed ID: 18067894 [Abstract] [Full Text] [Related]
2. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. Lund TD, Hinds LR, Handa RJ. J Neurosci; 2006 Feb 01; 26(5):1448-56. PubMed ID: 16452668 [Abstract] [Full Text] [Related]
3. The androgen metabolite, 5α-androstane-3β,17β-diol (3β-diol), activates the oxytocin promoter through an estrogen receptor-β pathway. Hiroi R, Lacagnina AF, Hinds LR, Carbone DG, Uht RM, Handa RJ. Endocrinology; 2013 May 01; 154(5):1802-12. PubMed ID: 23515287 [Abstract] [Full Text] [Related]
4. A role for the androgen metabolite, 5alpha-androstane-3beta,17beta-diol, in modulating oestrogen receptor beta-mediated regulation of hormonal stress reactivity. Handa RJ, Weiser MJ, Zuloaga DG. J Neuroendocrinol; 2009 Mar 01; 21(4):351-8. PubMed ID: 19207807 [Abstract] [Full Text] [Related]
5. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells. Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM, Handa RJ. Endocrinology; 2005 Jan 01; 146(1):147-55. PubMed ID: 15471969 [Abstract] [Full Text] [Related]
6. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats. Oliveira AG, Coelho PH, Guedes FD, Mahecha GA, Hess RA, Oliveira CA. Steroids; 2007 Dec 01; 72(14):914-22. PubMed ID: 17854852 [Abstract] [Full Text] [Related]
7. Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells. Pak TR, Chung WC, Hinds LR, Handa RJ. Endocrinology; 2007 Jul 01; 148(7):3371-82. PubMed ID: 17412808 [Abstract] [Full Text] [Related]
8. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Guerini V, Sau D, Scaccianoce E, Rusmini P, Ciana P, Maggi A, Martini PG, Katzenellenbogen BS, Martini L, Motta M, Poletti A. Cancer Res; 2005 Jun 15; 65(12):5445-53. PubMed ID: 15958594 [Abstract] [Full Text] [Related]
9. Arginine vasopressin regulation in pre- and postpubertal male rats by the androgen metabolite 3beta-diol. Pak TR, Chung WC, Hinds LR, Handa RJ. Am J Physiol Endocrinol Metab; 2009 Jun 15; 296(6):E1409-13. PubMed ID: 19383875 [Abstract] [Full Text] [Related]
10. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism. Hanamura T, Niwa T, Nishikawa S, Konno H, Gohno T, Tazawa C, Kobayashi Y, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S. Breast Cancer Res Treat; 2013 Jun 15; 139(3):731-40. PubMed ID: 23780684 [Abstract] [Full Text] [Related]
11. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern. Pérez-Palacios G, Santillán R, García-Becerra R, Borja-Cacho E, Larrea F, Damián-Matsumura P, González L, Lemus AE. J Endocrinol; 2006 Sep 15; 190(3):805-18. PubMed ID: 17003281 [Abstract] [Full Text] [Related]
12. An estrogenic effect of 5alpha-androstane-3beta, 17beta-diol on the behavioral response to stress and on CRH regulation. Huang Q, Zhu H, Fischer DF, Zhou JN. Neuropharmacology; 2008 Jun 15; 54(8):1233-8. PubMed ID: 18457850 [Abstract] [Full Text] [Related]
13. Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse. Lund TD, Munson DJ, Haldy ME, Handa RJ. Neurosci Lett; 2004 Jul 15; 365(1):43-7. PubMed ID: 15234470 [Abstract] [Full Text] [Related]
14. A role for the androgen metabolite, 5alpha androstane 3beta, 17beta diol (3β-diol) in the regulation of the hypothalamo-pituitary-adrenal axis. Handa RJ, Sharma D, Uht R. Front Endocrinol (Lausanne); 2011 Jul 15; 2():65. PubMed ID: 22649380 [Abstract] [Full Text] [Related]
15. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study. Chen J, Wang WQ, Lin SX. J Steroid Biochem Mol Biol; 2013 Sep 15; 137():316-21. PubMed ID: 23416106 [Abstract] [Full Text] [Related]
16. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation. Nunlist EH, Dozmorov I, Tang Y, Cowan R, Centola M, Lin HK. J Steroid Biochem Mol Biol; 2004 Jul 15; 91(3):157-70. PubMed ID: 15276623 [Abstract] [Full Text] [Related]